Variability in Antibiotic Use Across PICUs

被引:36
作者
Brogan, Thomas V. [1 ]
Thurm, Cary [2 ]
Hersh, Adam L. [3 ]
Gerber, Jeffrey S. [4 ]
Smith, Michael J. [5 ]
Shah, Samir S. [6 ,7 ,8 ]
Courter, Joshua D. [8 ,9 ]
Patel, Sameer J. [10 ]
Parker, Sarah K. [11 ,12 ,13 ]
Kronman, Matthew P. [14 ]
Lee, Brian R. [15 ]
Newland, Jason G. [16 ]
机构
[1] Univ Washington, Sch Med, Dept Pediat, Div Pediat Crit Care Med,Seattle Childrens Hosp, Seattle, WA 98195 USA
[2] Childrens Hosp Assoc, Lenexa, KS USA
[3] Univ Utah, Dept Pediat, Div Pediat Infect Dis, Salt Lake City, UT USA
[4] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA
[5] Univ Louisville, Sch Med, Div Pediat Infect Dis, Louisville, KY 40292 USA
[6] Cincinnati Childrens Hosp Med Ctr, Div Hosp Med, Cincinnati, OH 45229 USA
[7] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA
[8] Univ Cincinnati, Coll Med, Cincinnati, OH USA
[9] Cincinnati Childrens Hosp Med Ctr, Div Hosp Med, Cincinnati, OH 45229 USA
[10] Ann & Robert H Lurie Childrens Hosp Chicago, Div Infect Dis, Chicago, IL 60611 USA
[11] Univ Colorado, Sch Med, Div Infect Dis, Dept Pediat, Aurora, CO USA
[12] Univ Colorado, Sch Med, Div Infect Dis, Dept Infect Control, Aurora, CO USA
[13] Childrens Hosp Colorado, Aurora, CO USA
[14] Univ Washington, Sch Med, Seattle Childrens Hosp, Div Infect Dis, Seattle, WA USA
[15] Childrens Mercy Hosp Kansas City, Div Infect Dis, Kansas City, MO USA
[16] Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA
基金
美国医疗保健研究与质量局;
关键词
antimicrobial stewardship; children's hospitals; complex chronic conditions; critical care; pediatric intensive care units; transplantation; PEDIATRIC INTENSIVE-CARE; ANTIMICROBIAL STEWARDSHIP; MORTALITY; EXPOSURE; CHILDREN; IMPROVEMENT; GUIDELINES; MANAGEMENT; RESISTANCE; OUTCOMES;
D O I
10.1097/PCC.0000000000001535
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: To characterize and compare antibiotic prescribing across PICUs to evaluate the degree of variability. Design: Retrospective analysis from 2010 through 2014 of the Pediatric Health Information System. Setting: Forty-one freestanding children's hospital. Subjects: Children aged 30 days to 18 years admitted to a PICU in children's hospitals contributing data to Pediatric Health Information System. Interventions: To normalize for potential differences in disease severity and case mix across centers, a subanalysis was performed of children admitted with one of the 20 All Patient Refined-Diagnosis Related Groups and the seven All Patient Refined-Diagnosis Related Groups shared by all PICUs with the highest antibiotic use. Results: The study included 3,101,201 hospital discharges from 41 institutions with 386,914 PICU patients. All antibiotic use declined during the study period. The median-adjusted antibiotic use among PICU patients was 1,043 days of therapy/1,000 patient-days (interquartile range, 977-1,147 days of therapy/1,000 patient-days) compared with 893 among non-ICU children (interquartile range, 805-968 days of therapy/1,000 patient-days). For PICU patients, the median adjusted use of broad-spectrum antibiotics was 176 days of therapy/1,000 patient-days (interquartile range, 152-217 days of therapy/1,000 patient-days) and was 302 days of therapy/1,000 patient-days (interquartile range, 220-351 days of therapy/1,000 patient-days) for antimethicillin-resistant Staphylococcus aureus agents, compared with 153 days of therapy/1,000 patient-days (interquartile range, 130-182 days of therapy/1,000 patient-days) and 244 days of therapy/1,000 patient-days (interquartile range, 203-270 days of therapy/1,000 patient-days) for non-ICU children. After adjusting for potential confounders, significant institutional variability existed in antibiotic use in PICU patients, in the 20 All Patient Refined-Diagnosis Related Groups with the highest antibiotic usage and in the seven All Patient Refined-Diagnosis Related Groups shared by all 41 PICUs. Conclusions: The wide variation in antibiotic use observed across children's hospital PICUs suggests inappropriate antibiotic use.
引用
收藏
页码:519 / 527
页数:9
相关论文
共 28 条
[1]   Identifying priorities to improve.paediatric in-hospital antimicrobial use by cross-sectional evaluation of prevalence and appropriateness of prescription [J].
Alfredo Goycochea-Valdivia, Walter ;
Moreno-Ramos, Francisco ;
Ramon Pano-Pardo, Jose ;
Javier Aracil-Santos, Francisco ;
Baquero-Artigao, Fernando ;
del Rosal-Rabes, Teresa ;
Jose Mellado-Pena, Maria ;
Escosa-Garcia, Luis .
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2017, 35 (09) :556-562
[2]  
[Anonymous], LANCET INFECT DIS
[3]  
[Anonymous], EURO SURVEILL
[4]   Point Prevalence Survey of Antimicrobial Utilization in the Cardiac and Pediatric Critical Care Unit [J].
Blinova, Ekaterina ;
Lau, Elaine ;
Bitnun, Ari ;
Cox, Peter ;
Schwartz, Steven ;
Atenafu, Eshetu ;
Yau, Yvonne ;
Streitenberger, Laurie ;
Parshuram, Christopher S. ;
Marshall, John ;
Seto, Winnie .
PEDIATRIC CRITICAL CARE MEDICINE, 2013, 14 (06) :E280-E288
[5]  
Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]
[6]   The Science of Choosing Wisely - Overcoming the Therapeutic Illusion [J].
Casarett, David .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (13) :1203-1205
[7]   The relationship between antimicrobial resistance and patient outcomes: Mortality, length of hospital stay, and health care costs [J].
Cosgrove, SE .
CLINICAL INFECTIOUS DISEASES, 2006, 42 :S82-S89
[8]  
Dassner AM, 2017, CURR PEDIATR REV, V13, P49, DOI 10.2174/1573396312666161205102221
[9]  
Davey P, 2017, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003543.pub4, 10.1002/14651858.CD003543.pub3]
[10]   Bacteraemia incidence, causative organisms and resistance patterns, antibiotic strategies and outcomes in a single university hospital ICU: continuing improvement between 2000 and 2013 [J].
De Santis, Vincenzo ;
Gresoiu, Mihaela ;
Corona, Alberto ;
Wilson, A. Peter R. ;
Singer, Mervyn .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (01) :273-278